# AquIRE reveals the mechanisms of clinically induced RNA damage and the conservation and dynamics of glycoRNAs

**Authors:** Zijian Zhang, Zornitsa Vasileva Kotopanova, Kexin Dang, Xiangxu Kong, Nicole Simms, Tin Wai Yuen, Lan Lam, Lauren Forbes Beadle, Emma Hilton, Taqdees Qureshi, Marianna Coppola, Callum David Holmes, Kwan Ting Kan, Mark Ashe, Patrick Gallois, Hilary Ashe, Michael Braun, Mark Saunders, Paul Sutton, David J Thornton, John R P Knight

PMC · DOI: 10.1093/nar/gkag080 · 2026-02-05

## TL;DR

This paper introduces AquIRE, a new method to study RNA modifications and damage, revealing insights into how drugs affect RNA and the role of glycoRNAs in various biological processes.

## Contribution

AquIRE is a novel, sensitive method for quantifying RNA modifications and damage, enabling new discoveries about glycoRNAs and drug-induced RNA changes.

## Key findings

- RNA damage is widespread and follows previously unappreciated temporal dynamics in response to clinical compounds.
- AquIRE detects glycoRNAs across multiple species and identifies their dynamic expression during development and senescence.
- Cell surface or cell-free RNA promotes the cytotoxicity of RNA-damaging chemotherapy.

## Abstract

RNA is subject to many modifications, from small chemical changes like methylation to conjugation of biomolecules such as glycans. As well as endogenously written modifications, RNA is also exposed to damage induced by its environment. Certain clinical compounds are known to covalently modify RNA with a growing appreciation of how these impact clinical efficacy. To understand the regulation of these modifications, we need a reliable, sensitive, and rapid methodology for their quantification. Thus, we developed Aqueous Identification of RNA Elements (AquIRE) and applied it to the analysis of drug-induced RNA damage by 5FU, oxaliplatin, and temozolomide in clinically relevant cell models. We demonstrate that RNA damage is widespread and follows previously unappreciated temporal dynamics. AquIRE also provides a highly sensitive method to detect RNAs modified by glycans. We leverage this to expand the horizons of the glycoRNA world across the kingdoms of life as well as identifying cell-free glycoRNAs in multiple species. We demonstrate that glycoRNA expression is dynamic during embryo development, modulated during senescence, and elevated by RNA-damaging agents. Finally, we use RNA digestion to demonstrate that cell surface or cell-free RNA promotes the cytotoxicity of RNA-damaging chemotherapy. Together, the AquIRE platform provides an intrinsically flexible method to study diverse RNA modifications from any sample.

Graphical Abstract

## Linked entities

- **Chemicals:** 5FU (PubChem CID 3385), oxaliplatin (PubChem CID 9887053), temozolomide (PubChem CID 5394)

## Full-text entities

- **Genes:** TYMS (thymidylate synthetase) [NCBI Gene 7298] {aka DKCD, HST422, TMS, TS}, RNASE1 (ribonuclease A family member 1, pancreatic) [NCBI Gene 6035] {aka RAC1, RIB1, RNS1}, TAT (tyrosine aminotransferase) [NCBI Gene 6898], GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, DBA [NCBI Gene 8378], ALKBH3 (alkB homolog 3, alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 221120] {aka ABH3, DEPC-1, DEPC1, PCA1, hABH3}, METTL3 (methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit) [NCBI Gene 56339] {aka IME4, M6A, MT-A70, Spo8, hMETTL3}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}
- **Diseases:** CRC (MESH:D015179), inflammation (MESH:D007249), viral infections (MESH:D014777), Cancer (MESH:D009369), mucinous (MESH:D002288), cytotoxicity (MESH:D064420), autoimmunity (MESH:D001327), glioblastoma (MESH:D005909)
- **Chemicals:** m6A (MESH:C005955), agar (MESH:D000362), Psi (MESH:D011560), UTP (MESH:D014544), CO2 (MESH:D002245), carboplatin (MESH:D016190), SC (MESH:D012538), DTT (MESH:D004229), fluorine (MESH:D005461), HEPES (MESH:D006531), formamide (MESH:C031066), Glycan (MESH:D011134), methylene (MESH:C030011), KCl (MESH:D011189), water (MESH:D014867), NaCl (MESH:D012965), 5FU (MESH:D005472), cycloheximide (MESH:D003513), Nucleotide (MESH:D009711), Triton X-100 (MESH:D017830), acetate (MESH:D000085), ethanol (MESH:D000431), EDTA (MESH:D004492), sodium hypochlorite (MESH:D012973), SCD (MESH:C536778), DMSO (MESH:D004121), CaCl2 (MESH:D002122), oligodT (MESH:C027903), Temozolomide (MESH:D000077204), Cisplatin (MESH:D002945), poly(A) (MESH:D011061), sucrose (MESH:D013395), ice (MESH:D007053), ATP (MESH:D000255), DMEM (-), Ac4GalNAz (MESH:C528775), cytosine (MESH:D003596), guanidine hydrochloride (MESH:D019791), L-glutamine (MESH:D005973), MgSO4 (MESH:D008278), sodium (MESH:D012964), MgCl2 (MESH:D015636), BrdU (MESH:D001973), MOPS (MESH:C008550), biotin (MESH:D001710), m7G (MESH:C016578), tri-sodium citrate (MESH:C514290), Trizol (MESH:C411644), formaldehyde (MESH:D005557), galactose-1-phosphate (MESH:C029973), heparin (MESH:D006493), sodium dodecyl sulphate (MESH:D012967), Oxaliplatin (MESH:D000077150), platinum (MESH:D010984), DAPI (MESH:C007293), GlutaMAX (MESH:C054122), Benzyl-alpha-GalNAc (MESH:C080739), adenosine (MESH:D000241), D-glucose (MESH:D005947), N-acetyl-D-galactosamine (MESH:D000116)
- **Species:** Homo sapiens (human, species) [taxon 9606], Diptera (flies, order) [taxon 7147], Escherichia coli (E. coli, species) [taxon 562], Bos taurus (bovine, species) [taxon 9913], Drosophila melanogaster (fruit fly, species) [taxon 7227], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Capra hircus (domestic goat, species) [taxon 9925], Xenopus laevis (African clawed frog, species) [taxon 8355], Xenopus tropicalis (tropical clawed frog, species) [taxon 8364], Arabidopsis thaliana (mouse-ear cress, species) [taxon 3702], Malus domestica (apple, species) [taxon 3750]
- **Cell lines:** U251 — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0021), K-12 — Felis catus (Cat), Feline mammary carcinoma, Cancer cell line (CVCL_IX41), LS174T — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_1384), JVE-253 — Homo sapiens (Human), Colon mucinous adenocarcinoma, Cancer cell line (CVCL_EG28), RKO — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0504), A172 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0131), TOP10 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TT29), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), Col-0 — Homo sapiens (Human), Familial hypertrophic cardiomyopathy type 26, Induced pluripotent stem cell (CVCL_A6XE), JVE-127 — Homo sapiens (Human), Colon mucinous adenocarcinoma, Cancer cell line (CVCL_EG22), DLD1 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0248)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12873605/full.md

---
Source: https://tomesphere.com/paper/PMC12873605